Showing results (201-210 of 223) with videos related to

Sort By:
Pageof 23
The New England Journal of Medicine|May 6, 2026
Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic CancerBrian M Wolpin, Wungki Park, Ignacio Garrido-Laguna, et al.
The New England Journal of Medicine|June 1, 2026
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic CancerEileen M O'Reilly, Zev A Wainberg, Andrew E Hendifar, et al.
Ebiomedicine|October 30, 2025
Safety and efficacy of intratumourally administered INT230-6 in adult patients with advanced solid tumours: results from an open-label phase 1/2 dose escalation studyJacob S Thomas, Lillian L Siu, Matthew Ingham, et al.
JCI Insight|May 18, 2021
Protein synthesis inhibitor omacetaxine is effective against hepatocellular carcinomaLing Li, Gilad Halpert, Michael G Lerner, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|January 2, 2023
Impact of the COVID-19 Pandemic on Liver Cancer Staging at a Multidisciplinary Liver Cancer ClinicDaniel Li, Angela Y Jia, Jane Zorzi, et al.
Oncotarget|February 11, 2017
Combination epigenetic therapy in metastatic colorectal cancer (mCRC) with subcutaneous 5-azacitidine and entinostat: a phase 2 consortium/stand up 2 cancer studyNilofer S Azad, Anthony El-Khoueiry, Jun Yin, et al.
Cancer Medicine|December 27, 2019
A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancerMark Yarchoan, Chiung-Yu Huang, Qingfeng Zhu, et al.
The Lancet. Gastroenterology & Hepatology|July 14, 2019
Safety and activity of ivosidenib in patients with IDH1-mutant advanced cholangiocarcinoma: a phase 1 studyMaeve A Lowery, Howard A Burris, Filip Janku, et al.
Hepatology (Baltimore, Md.)|July 1, 2025
Tumor site influences efficacy of MEKi and immunotherapy combinations in a preclinical model of cholangiocarcinomaJacklyn N Hammons, Emilie K Warren, Megen C Wittling, et al.
Nature Communications|November 12, 2024
Entinostat in combination with nivolumab in metastatic pancreatic ductal adenocarcinoma: a phase 2 clinical trialMarina Baretti, Ludmila Danilova, Jennifer N Durham, et al.
Pageof 23